Home Blog Page 1085

Precision for Medicine Broadens Global Footprint with Singapore Office Opening

Singapore Office Expands APAC Presence to Seven Locations, Delivering Enhanced Local Expertise and Global Scale

BETHESDA, Md., Feb. 6, 2026 /PRNewswire/ — Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development, has announced the opening of a new office in Singapore. This strategic expansion strengthens Precision’s significant presence across the Asia-Pacific (APAC) region, serving as a crucial hub for enhanced client support and accelerated regional growth.

“This expansion, particularly with our new Singapore hub, signifies a major step in deepening our operational capabilities and localized expertise across APAC,” said Jing Ping Yeo, Vice President, Clinical Operations. “By expanding in critical markets like Singapore, we’re providing our clients with greater assurance on trial oversight and delivery, accelerating site activation and ultimately ensuring more efficient and higher-quality execution of complex, biomarker-driven clinical programs for patients worldwide.”

Singapore’s central location and sophisticated infrastructure make it ideal for growing Precision’s regional presence, including Mainland China, Hong Kong, India, South Korea, Taiwan and Australia. Through its expanded footprint, embedded senior leaders and a dedicated team of over 500 employees, Precision underscores its commitment to navigating the complexities of regional drug development and commercialization.

For its global partners, APAC expansion solidifies Precision as a single, unified CRO, eliminating the friction and complexity of managing multiple partners while offering streamlined oversight, clearer lines of accountability, and greater assurance regarding the quality and consistency of trial delivery. Conversely, for regional clients, this enhanced capability empowers them to effectively bring their ground-breaking therapies to global development pathways across the U.S. and Europe.

The Precision team features oversight from recognized leaders in several regions of APAC, such as Dr. Yeo, who also chairs the Drug Information Association (DIA) Singapore Advisory Committee and the Singapore Clinical Research Professionals Association (SCRP) and serves on the Program Committee for DIA-Asia, and operational capabilities in the region.

“The new Singapore office is a strategic pillar in our mission to be the unified partner for precision medicine development, both globally and within the dynamic APAC landscape,” said James Cheong, Senior Vice President, APAC. “This strategic hub facilitates the seamless integration of our extensive global expertise with local insights from our regional teams, positioning us to deliver accelerated solutions and deeper support to our clients.”

“The opening of our Singapore office is a pivotal moment that significantly strengthens Precision’s already robust APAC footprint,” said Daisy DeWeese-Gatt, President, Clinical Solutions, Precision for Medicine. “By better integrating diverse APAC data and patient populations, we can advance new medicines faster, ensuring therapies are better tailored and more representative of real-world diversity for patients globally with high unmet needs.”

About Precision for Medicine
Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise and advanced data intelligence. This convergence is driving faster clinical development and approval. Precision for Medicine is part of Precision Medicine Group, with 3,700 people in over 50 locations globally across North America, Europe and Asia-Pacific. For more information, visit PrecisionForMedicine.com.

Contact
Brad Epstein
Brad.Epstein@PrecisionMedicineGrp.com

Iyuno Achieves ISO27001 Certification, Reinforcing Its Commitment to Security & Trust

BURBANK, Calif., Feb. 6, 2026 /PRNewswire/ — Iyuno has successfully achieved ISO27001 certification, a globally recognized standard for information security management. This milestone reflects Iyuno’s commitment to security best practices and the ongoing work to protect content, data and operations across its global footprint.

Iyuno Achieves ISO279001 Certification, Reinforcing Its Commitment to Security & Trust
Iyuno Achieves ISO279001 Certification, Reinforcing Its Commitment to Security & Trust

“Our teams have worked with real focus to align Iyuno to the ISO27001 framework,” said Allan Dembry, Iyuno Chief Security & IT Officer. “Security doesn’t exist in isolation. Achieving ISO27001 helps us contribute more meaningfully to the broader ecosystem by bringing consistent, reliable practices to our work with clients and partners.”

ISO27001 provides a framework for identifying, managing and reducing risks through well-defined processes that span technology, governance, and daily operations.

This certification reinforces Iyuno’s security-first approach and provides a strong foundation as the company continues to partner with clients, creators, and technology providers across the industry.

ABOUT IYUNO 

Iyuno (www.iyuno.com) is a leading provider of localization services for the media and entertainment industry. Trusted by top entertainment brands and creators worldwide, Iyuno offers comprehensive end-to-end localization services from 45 offices across 29 countries. Backed by a team of exceptional creative and technical talent, state-of-the-art facilities, and cutting-edge technologies, Iyuno proudly boasts the largest global footprint amplifying its dubbing, subtitling and media services offerings.

voco Bangkok Surawong: The first property under voco hotels opens in Thailand

BANGKOK, Feb. 6, 2026 /PRNewswire/ — IHG Hotels & Resorts announces the opening of voco Bangkok Surawong, marking the debut of IHG’s fastest growing premium brand, voco hotels, in Thailand.

The hotel design and experience reflect Surawong’s vibrant spirit
The hotel design and experience reflect Surawong’s vibrant spirit

Each voco property is characterised by its individual charm, which provides guests with something unique while creating an inviting and unstuffy atmosphere for guests to truly unwind and feel at ease. Infused with charming personal touches and subtle Thai influences, voco Bangkok Surawong is a great gateway to explore Bangkok.

“We are thrilled to introduce voco hotels to Thailand, and offer travellers a stay that is upscale, familiar yet refreshingly different. We look forward to inviting guests to immerse in the brand’s playful nature and enjoy delightful, uplifting voco experiences provided by our thoughtful hosts here in Surawong,” said Walid Ouezini, General Manager, voco Bangkok Surawong.

Award-winning Thai architecture firm A49 refashioned the Brutalist modernism of the original Tawana Hotel, by blending heritage with contemporary openness through preserved geometric forms, natural light, and thoughtful architectural flow. Within the hotel, Thai interior design studio, P49 Deesign brings mid-century charm to life in true voco’s warm, playful style—balancing retro character, Thai artistry and modern comfort to reflect Surawong’s vibrant spirit.

Guests are invited to ‘come on in’ and are greeted with a signature voco welcome treat that is unique and representative of the local area, and a swift check-in. At voco Bangkok Surawong, guests will enjoy mango sticky rice cookie – a modern take on the classic Thai dessert that is carefully prepared by the hotel’s pastry chef daily with fresh local mangoes.

‘Me time’ beckons in its 244 thoughtfully designed guestrooms and suites. Staying true to voco hotel’s “step by step” sustainability mantra, voco Bangkok Surawong is committed to innovation and sustainability, and the belief that small steps collectively make the biggest difference. This includes pillows and duvet fillings made from recycled materials and premium organic New Zealand bulk bath amenities from Antipodes.

Outstanding dining experiences offer a taste of the ‘voco life’ at the hotel’s three dynamic restaurants and bars, including:

  • Tasca Sabio – a spirited Spanish-inspired restaurant and bar where bold Mediterranean flavours, lively sangria rituals and small plates made for sharing create an atmosphere perfect for friends to gather.
  • Deckles Smokehouse – the all-day-dining restaurant that offers a Bangkok’s premium hotel smokehouse experience, where slow-smoking traditions meet vibrant spices and craft cocktails

Additional amenities include a full lap pool set amidst landscaped gardens on the fourth floor, 24-hour fitness centre and an onsen spa.

The hotel also offers an elegant ballroom that seats up to 200 guests as well as four flexible meeting room spaces with the latest AV tech and stylish contemporary interiors – suitable for mid-scale conferences, events, and meetings.

Located along Surawong Road, the hotel sits at the midst of Bangkok’s heritage and modern energy—steps away from the bustling Silom district, Sathorn’s corporate hub, and Siam’s shopping and entertainment landmarks. With its lively neighbourhood charm, Surawong has long been known as a place of welcome, making it the perfect home for voco’s warm, stylish, and refreshingly different approach to hospitality.

Launched in 2018, voco hotels by IHG has quickly become one of IHG Hotels & Resorts’ fastest growing with 117 open hotels and 108 exciting destinations in the pipeline, including the recently opened voco Quang Binh Resort and voco Bandung Setiabudi.

For more information on voco Bangkok Surawong, please visit http://www.vocohotels.com/bkksurawong.

Press Kit available here and please credit IHG Hotels & Resorts for use of images.

*Figures as of 30 September 2025

 

EBANX appoints Eduardo de Abreu as Chief Product Officer to lead global product strategy from Singapore

With 11 years at the company, Abreu will also serve as CEO of EBANX Singapore, leading regulatory engagement and strengthening ties with APAC merchants

CURITIBA, Brazil and SINGAPORE, Feb. 6, 2026 /PRNewswire/ — EBANX, a global technology company specializing in payment services for emerging markets, today announced the appointment of Eduardo de Abreu as its new Chief Product Officer (CPO). Formerly Vice President of Product based in Brazil, Abreu will relocate to Singapore to lead EBANX’s global product roadmap as the company strengthens its presence in the APAC region.

Eduardo de Abreu, Chief Product Officer (CPO), EBANX
Eduardo de Abreu, Chief Product Officer (CPO), EBANX

Abreu joined the company in 2015, three years after its founding in Brazil. During EBANX’s early stages, he played a key role in building its foundational finance operations structure in Latin America. Over the past decade, he has led more than 20 teams, including Operations, Treasury, Sales Engineering, M&A, Pricing, and Merchant Success.

Eduardo’s trajectory at EBANX reflects his deep understanding of global payments, execution excellence, and total commitment to our merchants,” said João Del Valle, CEO and Co-founder of EBANX. 

As the payments sector demands constant adaptation and innovation—especially in emerging markets—my primary mission as CPO is to remain deeply connected to our merchants’ needs while keeping pace with the latest technologies,” stated Eduardo de Abreu, who was a key leader in EBANX’s expansion into Africa, India, and the Philippines in recent years. 

The relocation of the head of EBANX’s product to Singapore underscores a deepening investment in the APAC region, where merchant Total Payment Volume (TPV) grew 20% last year. With teams in Singapore, China, and India, EBANX serves more than 100 APAC merchants and connects global brands with customers across Asia, as well as Latin America and Africa.

Positioning our product leadership in Singapore brings EBANX closer to the world’s fastest-growing consumer markets and one of the most innovative payment ecosystems, reinforcing our commitment to serving merchants globally with best-in-class technology,” said Del Valle.

CEO of EBANX Singapore

The CPO will also serve as Chief Executive Officer (CEO) of EBANX Singapore, representing the company locally and before the Monetary Authority of Singapore (MAS). Last year, EBANX was granted a Major Payment Institution (MPI) license by the MAS. “We are well-positioned to offer advanced cross-border payments and merchant acquisition services while maintaining the highest regulatory and compliance standards,” explained Abreu.

EBANX’s announcement follows the recent appointment of Marin Mignot as Chief Operating Officer.

ABOUT EDUARDO DE ABREU

Eduardo de Abreu is the Chief Product Officer (CPO) of EBANX and the Chief Executive Officer (CEO) of EBANX Singapore. His mission is to align product strategy with business architecture in order to deliver customer-centric solutions. He also oversees engagement with the Monetary Authority of Singapore (MAS) and the strengthening of relationships with merchants across APAC. Abreu has previously served as Director of Global Payments, Director of Finance, Senior Manager of Business Architecture, Payments Manager, and Vice President of Product at the company. With more than 10 years at EBANX, Eduardo has extensive expertise in the financial and payment sectors, as well as in sales and business strategy. He holds a degree in Economic Sciences and a specialization in Production Engineering from the Federal University of Paraná (UFPR). Eduardo also holds an MBA in Strategic Business Management from Fundação Getúlio Vargas (FGV).

ABOUT EBANX

EBANX is the leading payments platform connecting global businesses to the world’s fastest-growing digital markets. Founded in 2012 in Brazil, EBANX was built with a mission to expand access to international digital commerce. Leveraging proprietary technology, deep market expertise, and robust infrastructure, EBANX enables global companies to offer hundreds of local payment methods and streamline cross-border payments across Latin America, Africa, and Asia. Officially licensed as a Major Payment Institution (MPI) by the Monetary Authority of Singapore (MAS), the company is committed to supporting merchants with full regulatory compliance. More than just payments, EBANX drives growth, enhances sales, and delivers seamless purchase experiences for businesses and end-users alike.

For further information, please visit:

Website: https://www.ebanx.com/en/     
LinkedIn: https://www.linkedin.com/company/ebanx

Media Contact:
Shan Huang
shan.huang@ahgstrategies.com 

World’s First Serum-Free Iterative Rabies Vaccine from AIM Successfully Passes On-Site Registration Inspections and Is Imminent for Launch

HONG KONG, Feb. 6, 2026 /PRNewswire/ — Poised to Fill the Global Market Gap, the Serum-Free Iterative Rabies Vaccine Approaches a Critical Milestone in Commercialization. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on February 5 that its wholly-owned subsidiary AIM Rongyu’s world’s first independently developed serum-free iterative rabies vaccine has successfully passed the National Medical Products Administration (NMPA) on-site inspection for drug clinical trials and the on-site inspection for drug registration and production. This marks a major step forward for this highly anticipated innovative product toward commercialization. 

According to the unblinded results from the completed Phase III clinical study, AIM’s serum-free iterative rabies vaccine demonstrates excellent safety, immunogenicity, and immune persistence, fully meeting the predefined evaluation criteria for the clinical trial. Previously, AIM Rongyu had already obtained the corresponding product production license for the serum-free iterative rabies vaccine. Currently, no serum-free rabies vaccine has been approved for marketing anywhere in the global market, positioning AIM’s groundbreaking innovative vaccine to fill this significant market gap. 

According to the latest data from the Chinese Center for Disease Control and Prevention, after a period of decline, human rabies incidence and deaths have shown a rebound since 2024, with a notable increase of approximately 50% year-on-year in 2025. The current prevention and control situation highlights the urgent market demand for safer and more effective vaccines, providing broad space for the launch of new vaccines. According to statistics from China Insights Consultancy, driven by product updates and iterations as well as increased rabies vaccine coverage, the rabies vaccine market is expected to reach RMB14.8 billion by 2030. 

Leveraging its technological iterative advantages, the serum-free iterative rabies vaccine is poised to capture a leading market share. As per AIM Vaccine’s announcement, this product is completely distinct from and represents an iterative upgrade over traditional Vero cell rabies vaccines and human diploid rabies vaccines. It contains no animal serum, significantly enhancing safety and reducing the probability of adverse reactions. The National “Rabies Exposure Prevention and Disposal Work Specification (2023 Edition)” requires rabies vaccination clinics to be equipped with at least two different types of rabies vaccines, and AIM’s serum-free rabies vaccine, with its iterative technological advantages, is expected to become the preferred choice for vaccination institutions. 

More importantly, AIM’s robust commercialization network provides strong assurance for the rapid market coverage of the new product. The company’s sales channels span all 31 provinces nationwide and have successfully exported multiple products, including rabies vaccines, to various overseas markets. 

As a key supplier in the domestic rabies vaccine field, AIM has completed an iterative upgrade pathway from Vero cell rabies vaccines to human diploid cell rabies vaccines, serum-free rabies vaccines, and onward to mRNA rabies vaccines. This fully demonstrates the company’s ability to grasp market trends and meet clinical needs. This strategy not only increases the company’s market share but also significantly enhances product pricing power and profitability. 

Xiangcai Securities stated in its January report this year that product market demand and pipeline innovation capabilities will be the core competitiveness of vaccine companies. 

Fosun International Securities’ research report explicitly pointed out that the unit price of human diploid cell rabies vaccines can reach 4-5 times that of Vero cell rabies vaccines, and it is expected that the company’s rabies vaccine product line sales will grow rapidly. With its first-mover advantages in the serum-free rabies vaccine and mRNA rabies vaccine fields, AIM Vaccine is poised to capture more than one-third of the global market share in the future. 

In summary, AIM’s imminent launch of the serum-free iterative rabies vaccine, with its disruptive technological advantages, is expected to drive substantial performance growth for the company.

VARON Marks Valentine’s Day With Health-Focused Savings That Put Care First

Love looks like care. This Valentine’s Day, VARON invites families to show love in a way that helps loved ones breathe easier—at home and on the go.

NEW YORK, Feb. 6, 2026 /PRNewswire/ — VARON, a trusted provider of respiratory care solutions, today announced its Valentine’s Day Sale, a limited-time event designed to celebrate love through meaningful, health-forward gifts. Centered on comfort, mobility, and peace of mind, the event offers thoughtful savings across VARON’s lineup of portable oxygen concentrator and home oxygen concentrator options without losing sight of what matters most: care that supports daily breathing needs.

“Love looks like care,” said VARON CEO. “For many people, that means choosing products that help loved ones stay active, comfortable, and confident. This Valentine’s Day, we’re making it easier to give a gift that truly supports well-being.”

Celebrate Valentine’s Day with a gift that reflects lasting care, not just a single moment.

Valentine’s Day: Where Love, Care, and Health Meet

Valentine’s Day is often about romance, but at its heart, it’s about care. For many people, love shows up in quieter ways—checking in, offering support, and making daily life a little easier. Health-focused gifts, such as a reliable home oxygen concentrator or a lightweight oxygen concentrator, can be a powerful expression of that care, supporting comfort and independence long after the holiday has passed.

VARON’s Valentine’s Day event is designed around this idea: that caring for someone’s breathing is caring for their quality of life.

Valentine’s Day Offers Designed to Support Everyday Breathing

To make essential respiratory care more accessible, VARON is offering holiday pricing across its official store. All discounts are automatically applied at checkout for a simple, stress-free experience.

  • 18% Sitewide Discount across the entire VARON range
  • Free $30 VARON Gift Card with any machine purchase
  • Up to 40% Off Featured Products, available for a limited time

These offers are intended to help families invest in dependable oxygen support while managing healthcare costs.

Explore Valentine’s Day savings created to support long-term respiratory care.

Featured Portable and Home Oxygen Solutions

VARON’s featured Valentine’s Day products focus on reliability, comfort, and ease of use—key considerations when selecting a portable oxygen concentrator or home oxygen concentrator.

  • VP-8 Lite Portable Oxygen Concentrator
    A compact, lightweight oxygen concentrator with adjustable pulse flow and dual oxygen delivery modes, designed to support consistent oxygen needs during daily activities.
  • VP-6 Continuous Flow Portable Oxygen Concentrator
    Provides adjustable continuous flow oxygen with a built-in nebulizer function, supporting dependable care at home or while staying active.
  • VP-8G Ultra Portable Oxygen Concentrator
    Ultra-lightweight and easy to operate, offering multiple pulse flow settings and a large replaceable battery for flexible, everyday use.
  • VH-2 Pro Home Oxygen Concentrator
    Designed for home comfort with adjustable continuous flow, nebulization support, and an intuitive LED control panel.
  • Serene 3 and Serene 5 Home Oxygen Concentrators
    Medical-grade oxygen purity, quiet operation, and smooth mobility for consistent home-based respiratory support.

Bundle Options for Extended Confidence and Support

For individuals who need longer run times or added flexibility, VARON’s Valentine’s Day bundles pair oxygen concentrators with extra batteries and essential accessories. These thoughtfully assembled packages support extended use throughout the day, making them ideal for active routines or families seeking dependable travel oxygen concentrators for everyday outings.

Each bundle is designed to reduce interruptions and provide confidence wherever life happens.

Choose a bundle that keeps care going longer, without added complexity.

Why Families Trust the VARON Official Store

Shopping directly from VARON ensures peace of mind at every step. Customers benefit from high-quality products, competitive pricing, and dependable after-sales support. Every purchase includes official warranty coverage, fast U.S. shipping, flexible payment options, and access to dedicated customer care.

Valentine’s Day pricing is also protected by a 30-day price guarantee, reinforcing VARON’s commitment to transparency and trust.

A Valentine’s Gift That Gives Back

As part of the Valentine’s Day event, customers will receive a redeemable VARON gift card with qualifying purchases, usable for accessories or future needs. VARON also invites customers to share their experiences through reviews or social posts, rewarding participation with additional store credits through its customer rewards program.

It’s VARON’s way of celebrating the community built around better breathing and shared care.

Share your story and help others discover breathing support that truly matters.

About VARON

VARON is dedicated to improving everyday respiratory care through thoughtfully designed portable oxygen concentrator and home oxygen concentrator solutions. With a focus on comfort, reliability, and user-centered design, VARON supports individuals and families seeking better breathing and greater independence—today and for the long term.

Media Contact:

VARON Oxygen Concentrator
Email: official@varoninc.com
Website: www.varoninc.com

Monport Positions Laser Engraving as a Growing Trend for Valentine’s Day Personalized Gifts

NEW YORK, Feb. 6, 2026 /PRNewswire/ — As Valentine’s Day approaches, Monport Laser is highlighting how desktop laser engravers, industrial CO2 laser engraver cutting machines, and fiber laser engravers are increasingly used for customized gifts and personalized products. The company’s Valentine’s Day Sale, running Feb. 5 through Feb. 16, 2026, combines reward points, sitewide discounts, and product-specific inclusions, aligning with the growing trend of customizable Valentine’s Day gifts.

Laser engraving technology, once primarily used in industrial applications, is now popular among small businesses, hobbyists, and online creators. It allows consumers to craft one-of-a-kind gifts, including engraved jewelry, wooden plaques, acrylic keepsakes, and metal accessories. These personalized products are becoming a key element of Valentine’s Day gifting trends.

“Laser engraving enables makers and consumers to add names, dates, and custom designs to gifts, transforming ordinary items into meaningful keepsakes,” said Monport CEO.

Laser Engraving Technology for Valentine’s Day Personalization

Laser engraving technology has expanded from industrial applications to small business, artisan, and hobbyist markets. CO2 laser engraving machines are commonly used for softer materials such as wood, leather, acrylic, and glass, enabling creation of personalized plaques, keepsake boxes, photo frames, and acrylic love tokens.

Fiber laser engraver, in contrast, are optimized for metals, supporting precise marking for engraved rings, bracelets, keychains, and metal accessories. Together, these technologies allow creators to produce personalized gifts with detailed names, dates, or custom messages — aligning with the increasing consumer demand for differentiated Valentine’s Day presents.

“Laser engraving allows makers and consumers to transform ordinary items into meaningful keepsakes through precise customization,” said Monport CEO.

Monport Valentine’s Day Laser Machine Discount

Reward Points and Sitewide Discount

  • Reward points: Customers earn 5% of the order value for future purchases.
  • Sitewide discount: Automatic 6% off eligible laser engraver machines and accessories, automatically applied at checkout.

Machine-Specific Discounts and Inclusions

  • GPro Series Fiber Laser Engravers
    • Excluded from general machine sitewide discounts.
    • Instant $500 price reduction on all GPro Series Fiber Laser Engravers..
    • Suitable for creating custom wooden and acrylic Valentine’s gifts.
  • Fiber Laser Engravers
    • GT 200W Fiber Laser: Free 6W Diode Laser, ideal for engraved metal jewelry and small keepsakes.
    • GT Fiber Laser (excluding GT 200): Free F-theta Lens for precision metal marking.
    • GM & GM Pro Series Fiber Laser: Free F-theta Lens, supporting detailed metal engraving such as bracelets or keychains.
  • CO2 Laser Engraving Machines
    • Mega Series Desktop Laser Engraver: Free LightBurn Software for workflow management and creative design on wood, acrylic, and leather.
    • CO2 Industrial Laser Engraver: Free 2 Laser Marking Sprays and Cooling Liquid for medium-scale Valentine’s gift production.
    • Effi Series Industrial CO2 Laser Cutting Machine: Free 3 Laser Marking Sprays and Rotary Axis Attachment, enabling cylindrical engraving such as mugs or bottles.
    • Reno Series Desktop Laser Engraver: Free Laser Safety Glasses and 2 Laser Marking Sprays, suited for small-scale personalized projects.
  • Accessories
    • Mega Conveyor Belt: Excluded from general accessory discounts but receives instant $100 price reduction ($899.99$799.99).

Implications for Small Businesses and Makers

The combination of desktop laser engravers, fiber laser engravers, and CO2 laser engraving machines provides makers, small businesses, and artisans with tools to create high-quality, customized Valentine’s Day gifts. CO2 lasers are ideal for wood, leather, and acrylic materials, while fiber lasers enable precision engraving on metals. This alignment of technology and seasonal demand supports both creative production workflows and small-scale commercial applications.

Celebrate Valentine’s Day with a gift that tells a story. With Monport’s laser engraving solutions, your gifts become personal, meaningful, and unforgettable.

About Monport

Monport continues to prioritize innovation in personalization and business support, empowering small businesses, makers, and artisans to expand their creative capabilities. With practical incentives and tools, Monport reinforces its commitment to helping creators bring high-quality, personalized products to market efficiently and professionally.

For more information and to explore the full collection of CO2 laser and fiber laser engravers, visit Monport Laser official website.

Media Contact:
Company: Monport Laser
Email: official@monportlaser.com
Website: https://www.monportlaser.com/

 

 

This Valentine’s Day, VARON Encourages Filipinos to Show Love Through Better Respiratory Health

MANILA, Philippines, Feb. 5, 2026 /PRNewswire/ — Valentine’s Day is traditionally associated with flowers and chocolates, but health experts encourage Filipinos to also prioritize well-being for themselves and their loved ones. Respiratory health is increasingly important as more people manage chronic conditions, recover from illness, or maintain active lifestyles amid environmental challenges.

VARON Philippines marks the occasion by promoting oxygen care as a meaningful way to show love, emphasizing mobility, comfort, and peace of mind.

Love and Health: Caring Beyond Gifts

Beyond traditional gifts, Valentine’s Day is an opportunity to demonstrate lasting care through health. Investing in respiratory wellness supports independence, daily activity, and confidence, allowing families to enjoy more meaningful moments together.

“Love is about showing care in ways that last,” VARON CEO said. “This Valentine’s Day, we want to make it easier for families to invest in health, independence and everyday wellness.”

Sitewide 15% OFF, With Special 20% Valentine’s Deals

During the promotion, all VARON oxygen concentrators are available at 15% off, except for the following models and bundles, which are discounted at 20%:

  • VH-2 Pro home oxygen concentrator

  • VP-2 Pulse flow portable oxygen concentrator

  • VP-6 Continuous portable oxygen concentrator

  • VL-1 + 5000mAh Battery Bundle

  • VL-2 + 5000mAh Battery Bundle

New Technologies Supporting Everyday Wellness

VARON continues to expand its lineup with machines designed for comfort, efficiency and ease of use.

Battery Bundles: More Freedom, Better Value

VARON emphasized that the VL-1 and VL-2 battery bundles offer the most cost-effective option for users who prioritize mobility and portability.

With an extra 5000mAh battery included, these bundles allow for extended use without frequent recharging making them especially valuable for travel, outdoor activities, emergencies and active lifestyles.

Health as an Act of Love

As more Filipinos view health as a shared responsibility, Valentine’s Day serves as an opportunity to reflect on choices that support long-term well-being.

The Valentine’s Day initiative is available for a limited time through VARON’s official website.

Media Contact:

VARON Oxygen Solutions

Email: support@varoninc.ph

Website: https://varoninc.ph/